Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms
Ciarán Martin Fitzpatrick, B. Anderson, Gabrielle Agin-Liebes, Joseph Guydish
Journal of Psychoactive Drugs January 27, 2022 DOI: 10.1080/02791072.2021.1983673 via OpenAlex
Summary
AI-generated from the abstractA case report described a person with obsessive-compulsive disorder whose symptoms lessened after consuming psilocybin-containing mushrooms. The report prompted a letter arguing that psychedelic research has moved beyond case studies and that journals should prioritize publishing clinical trials over case reports.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A person with obsessive-compulsive disorder |
| Intervention | psilocybin-containing mushrooms |
| Topics | Psilocybin |
| Keywords | Psychiatry Consumption sociology Psychology Medicine |
| Citations | 1 |
| Key finding | Consumption of psilocybin-containing mushrooms was associated with reduction of obsessive-compulsive disorder symptoms in a single case. |
Abstract
The Journal of Psychoactive Drugs published a case study reporting reduction of obsessive-compulsive disorder (OCD) symptoms after consumption of psilocybincontaining mushrooms (Lugo-Radillo & Cortes-Lopez, 2021).We subsequently received a letter suggesting that psychedelic research has progressed beyond case studies, and recommending that journals focus on publication of clinical trials rather than case reports.